Citation Impact
Citing Papers
From NASH to HCC: current concepts and future challenges
2019
ROS in cancer therapy: the bright side of the moon
2020 Standout
Genetic inactivation of Nrf2 prevents clonal expansion of initiated cells in a nutritional model of rat hepatocarcinogenesis
2018
Thyroid Function and the Risk of Nonalcoholic Fatty Liver Disease: The Rotterdam Study
2016
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Hepatocellular carcinoma
2021 Standout
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
The Dual Roles of NRF2 in Cancer
2016
Direct effects of thyroid hormones on hepatic lipid metabolism
2018
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
MiR-30e suppresses proliferation of hepatoma cells via targeting prolyl 4-hydroxylase subunit alpha-1 (P4HA1) mRNA
2016
Thyroid Hormone Regulates Hepatic Expression of Fibroblast Growth Factor 21 in a PPARα-dependent Manner
2010
Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes
2009
Tri-iodothyronine upregulates adiponutrin mRNA expression in rat and human adipocytes
2009
Oxidative Stress in Cancer
2020 Standout
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation
2009
Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement
2014 Standout
Thyroid Hormone Analogues: Where Do We Stand in 2013?
2013
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Plasma Thyroid Hormone Concentration is Associated with Hepatic Triglyceride Content in Patients with Type 2 Diabetes
2016
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis
2016
Thyroid Hormone Regulation of Metabolism
2014 Standout
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Thyroid Hormone Receptor β Agonist Induces β-Catenin-Dependent Hepatocyte Proliferation in Mice: Implications in Hepatic Regeneration
2016
The Versatile Role of microRNA-30a in Human Cancer
2017 Standout
Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways
2013
NRF2 and microRNAs: new but awaited relations
2015
Nrf2, but not β‐catenin, mutation represents an early event in rat hepatocarcinogenesis
2015
Works of Pia Sulas being referenced
MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC)
2013
Thyroid hormone (T3) and TRβ agonist GC‐1 inhibit/reverse nonalcoholic fatty liver in rats
2008
A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis
2017
Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis
2015